OrthoPediatrics (NASDAQ:KIDS) Downgraded by Wall Street Zen to Sell

Key Points

• OrthoPediatrics' stock was downgraded from "hold" to "sell" by Wall Street Zen, highlighting concerns among analysts regarding the company's performance.
• The stock price objective was set at $18.00 by Truist Financial, while Lake Street Capital lowered its target from $37.00 to $34.00, indicating a more cautious outlook.
• Despite recent downgrades, OrthoPediatrics maintains a "Moderate Buy" average rating, with a target price of $26.29 according to analysts, although the stock has seen a decline of 9.2% recently.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Saturday.

KIDS has been the subject of several other reports. Truist Financial set a $18.00 price objective on shares of OrthoPediatrics in a research note on Friday. Lake Street Capital lowered their price objective on shares of OrthoPediatrics from $37.00 to $34.00 and set a "buy" rating for the company in a research note on Friday. Citigroup restated an "outperform" rating on shares of OrthoPediatrics in a report on Friday. Weiss Ratings restated a "sell (e+)" rating on shares of OrthoPediatrics in a report on Wednesday. Finally, BTIG Research reduced their target price on shares of OrthoPediatrics from $39.00 to $23.00 and set a "buy" rating on the stock in a report on Friday. Seven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, OrthoPediatrics presently has an average rating of "Moderate Buy" and an average price target of $26.29.

OrthoPediatrics Stock Down 9.2%

KIDS stock opened at $16.30 on Friday. The stock has a market capitalization of $408.64 million, a P/E ratio of -9.11 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66. OrthoPediatrics has a one year low of $15.28 and a one year high of $32.00. The company has a 50 day moving average price of $19.49 and a two-hundred day moving average price of $21.04.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its earnings results on Monday, January 9th. The company reported ($0.15) EPS for the quarter. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The firm had revenue of $25.08 million during the quarter. As a group, sell-side analysts expect that OrthoPediatrics will post -0.93 EPS for the current year.

Insider Buying and Selling

In other news, CFO Fred Hite acquired 5,076 shares of the business's stock in a transaction on Thursday, August 21st. The shares were purchased at an average price of $19.41 per share, for a total transaction of $98,525.16. Following the acquisition, the chief financial officer directly owned 213,065 shares of the company's stock, valued at $4,135,591.65. This represents a 2.44% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 32.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors have recently added to or reduced their stakes in KIDS. Los Angeles Capital Management LLC acquired a new position in OrthoPediatrics in the 2nd quarter worth $220,000. PDT Partners LLC acquired a new position in OrthoPediatrics in the 1st quarter worth $244,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock worth $246,000 after buying an additional 645 shares in the last quarter. GAMMA Investing LLC lifted its holdings in OrthoPediatrics by 4,618.2% in the 1st quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock worth $261,000 after buying an additional 10,391 shares in the last quarter. Finally, R Squared Ltd acquired a new position in OrthoPediatrics in the 2nd quarter worth $272,000. Institutional investors and hedge funds own 69.05% of the company's stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.